Articaine

阿替卡因
  • 文章类型: Journal Article
    研究利多卡因与肾上腺素局部麻醉的比较效果阿替卡因与肾上腺素在鼻内镜泪囊鼻腔吻合术(EN-DCR)中的应用。
    这项回顾性研究共包括180名患者。这些患者分为两组:利多卡因组,接受2%利多卡因(1:100,000肾上腺素),阿替卡因组,接受4%阿替卡因(1:100,000肾上腺素)局部麻醉。该研究比较了麻醉效果,术中疼痛水平,术中出血,以及两组之间心率和血压的差异。
    阿替卡因组与利多卡因组相比,显示出明显较低的视觉模拟评分(VAS)疼痛评分,测量在4.4±0.6厘米与5.0±1.0cm,分别为(P<0.0001)。此外,与利多卡因组相比,阿替卡因组表现出更高的麻醉效果(89.0%vs.76.6%,p=0.0487)。值得注意的是,与利多卡因组相比,阿替卡因组手术期间鼻粘膜出血较少(p=0.004).然而,两组患者血压、心率变化差异无统计学意义(p>0.05)。
    这项研究表明,与EN-DCR中的2%利多卡因(1:100,000肾上腺素)相比,4%阿替卡因(1:100,000肾上腺素)具有更好的临床疗效。
    UNASSIGNED: To investigate the comparative effects of local anesthesia using lidocaine with adrenaline vs. articaine with adrenaline in endoscopic endonasal dacryocystorhinostomy (EN-DCR).
    UNASSIGNED: This retrospective study included a total of 180 patients. These patients were categorized into two groups: the lidocaine group, which received 2% lidocaine (1:100,000 adrenaline), and the articaine group, which received 4% articaine (1:100,000 adrenaline) for local anesthesia. The study compared anesthesia efficacy, intraoperative pain levels, intraoperative bleeding, as well as differences in heart rate and blood pressure between the two groups.
    UNASSIGNED: The articaine group demonstrated a significantly lower visual analog scale (VAS) pain score when compared to the lidocaine group, measuring at 4.4 ± 0.6 cm vs. 5.0 ± 1.0 cm, respectively (P < 0.0001). Additionally, the articaine group exhibited a higher anesthesia efficacy compared to the lidocaine group (89.0% vs. 76.6%, p = 0.0487). Notably, the articaine group experienced less nasal mucosal bleeding during the surgery in contrast to the lidocaine group (p = 0.004). However, there were no statistically significant differences in changes in blood pressure and heart rate between the two groups (p > 0.05).
    UNASSIGNED: This study demonstrated that 4% articaine (1:100,000 adrenaline) has superior clinical effectiveness in comparison to 2% lidocaine (1:100,000 adrenaline) in EN-DCR.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    简介氧化应激,活性氧(ROS)产生和抗氧化防御之间的不平衡,在各种牙科疾病中起着重要作用。局部麻醉药经常用于牙科。牙科局部麻醉药的潜在抗氧化活性可有助于牙科实践。因此,本研究旨在探讨三种常用的牙科局部麻醉药的ROS清除活性,利多卡因,丙胺卡因,还有阿替卡因,重点研究它们对羟基自由基(HO•)和超氧阴离子(O2•-)的影响。材料和方法采用电子自旋共振(ESR)自旋捕获技术来专门测量不同浓度下这些局部麻醉剂的ROS清除活性。结果利多卡因,丙胺卡因,阿替卡因表现出浓度依赖性HO·-清除活性,IC50值为0.029%,0.019%,和0.014%,分别。利多卡因和丙胺卡因显示浓度依赖性O2•-清除活性,IC50值为0.033%和0.057%,分别。然而,阿替卡因未清除O2•-。结论积极使用局部麻醉药可通过直接清除ROS减轻氧化损伤和炎症损伤。然而,需要进一步的研究来阐明这些牙科局部麻醉药抗氧化作用的具体机制,以及它们对与氧化应激相关的牙科疾病的潜在影响.
    Introduction Oxidative stress, an imbalance between reactive oxygen species (ROS) production and antioxidant defenses, plays an important role in various dental diseases. Local anesthetics are frequently used in dentistry. The potential antioxidant activity of dental local anesthetics can contribute to dental practice. Therefore, this study aimed to investigate the ROS-scavenging activities of three commonly used dental local anesthetics, lidocaine, prilocaine, and articaine, focusing on their effects on hydroxyl radicals (HO•) and superoxide anions (O2 •-). Materials and methods The electron spin resonance (ESR) spin-trapping technique was employed to specifically measure the ROS-scavenging activities of these local anesthetics at varying concentrations. Results Lidocaine, prilocaine, and articaine exhibited concentration-dependent HO•-scavenging activities, with IC50 values of 0.029%, 0.019%, and 0.014%, respectively. Lidocaine and prilocaine showed concentration-dependent O2 •--scavenging activity, with IC50 values of 0.033% and 0.057%, respectively. However, articaine did not scavenge O2 •-. Conclusions The proactive use of dental local anesthetics may mitigate oxidative injury and inflammatory damage through direct ROS scavenging. However, further research is needed to elucidate the specific mechanisms underlying the antioxidant effects of these dental local anesthetics and their potential impact on the dental diseases associated with oxidative stress.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这个双盲,随机临床试验旨在确定在下牙槽神经阻滞(IANB)期间接受2%利多卡因和接受4%阿替卡因的患者的神经感觉障碍(NSD)患病率是否存在差异.接受第三磨牙拔除的患者被随机分为两组。IANB在第1组中使用2%利多卡因,在第2组中使用4%阿替卡因。记录了NSD的发生。患者在拔除牙齿后48小时和一周内就诊。麻醉药物的类型(4%阿替卡因对2%利多卡因)是研究的预测因素。两组共研究2400例患者(每组1200例)。患者的平均(范围)年龄为28.40(18-44)岁。利多卡因组5例(0.41%)和阿替卡因组7例(0.58%)注射后出现NSD(p=0.77)。阿替卡因组IANB后NSD的患病率并不高于利多卡因组。
    This double-blind, randomised clinical trial aimed to find out whether there is a difference in the prevalence of neurosensory disturbance (NSD) between patients who received 2% lidocaine and those who received 4% articaine during inferior alveolar nerve blocks (IANBs). Patients who underwent third molar extraction were randomised into two groups. IANB was performed using 2% lidocaine in Group 1 and 4% articaine in Group 2. The occurrence of NSD was documented. Patients were visited within 48 hours and one week after the tooth was removed. The type of anaesthetic drug (4% articaine versus 2% lidocaine) was the study\'s predictive factor. A total of 2400 patients were studied in two groups (1200 in each group). The mean (range) age of the patients was 28.40 (18-44) years. Five patients (0.41%) in the lidocaine group and seven (0.58%) in the articaine group had NSD after injection (p = 0.77). The prevalence of NSD after IANB was no higher in the articaine group than in the lidocaine group.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这项研究的目的是比较4%阿替卡因的麻醉效果,0.5%布比卡因和0.5%罗哌卡因(1:200,000肾上腺素)在手术切除下颌第三磨牙时。
    该研究包括75名患者,随机分为3组,每组25名患者。研究变量是:麻醉作用的开始,手术时间和麻醉和术后镇痛。使用视觉模拟量表来评估不同时间间隔的疼痛。统计分析显示,在使用的麻醉溶液的体积方面,组间差异无统计学意义。麻醉质量,手术难度和手术持续时间。
    阿替卡因(1.14min)的平均起效时间明显短于(P<0.001)罗哌卡因(2.18min)和布比卡因(2.33min)。然而,与阿替卡因(232.8min和191.4min)相比,布比卡因(483.6min和464min)和罗哌卡因(426.6min和459min)的麻醉和镇痛持续时间明显(P<0.001)更长,分别。此外,三组术后6小时疼痛评分比较,差异有统计学意义(P<0.01)。
    罗哌卡因和布比卡因可安全用于预期手术持续时间较长的患者。
    UNASSIGNED: The aim of this study was to compare the anesthetic efficacy of 4% articaine, 0.5% bupivacaine and 0.5% ropivacaine (with 1:200,000 adrenaline) during surgical removal of impacted mandibular third molars.
    UNASSIGNED: The study included 75 patients randomly divided into three equal groups of 25 patients each. The study variables were: onset of anesthetic action, duration of surgery and anesthesia and postoperative analgesia. A visual analog scale was used to assess pain at different time intervals. Statistical analysis revealed insignificant difference among groups in terms of volume of anesthetic solution used, quality of anesthesia, surgical difficulty and duration of surgery.
    UNASSIGNED: The mean onset time was significantly (P < 0.001) shorter for articaine (1.14 min) than ropivacaine (2.18 min) and bupivacaine (2.33 min). However, the duration of anesthesia as well as analgesia was significantly (P < 0.001) longer for bupivacaine (483.6 min and 464 min) and ropivacaine (426.6 min and 459 min) as compared to articaine (232.8 min and 191.4 min), respectively. Also, on comparing three groups pain scores at 6th postoperative hour were significant (P < 0.01).
    UNASSIGNED: Ropivacaine and bupivacaine can be safely used in patients where longer duration of surgery is anticipated.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本试验旨在研究阿替卡因在小儿牙髓治疗过程中的疼痛管理效果。
    方法:收集98例接受牙髓无痛治疗的患儿,随机分为对照组和观察组。每组49例。对照组采用利多卡因浸润麻醉,观察组采用阿替卡因浸润麻醉。麻醉效果,麻醉开始时间,感官恢复时间,麻醉持续时间,疼痛强度,血压,心率,并对不良反应进行比较。
    结果:观察组麻醉有效率高于对照组。麻醉起效时间和感觉恢复时间较短,麻醉持续时间较长,观察组VAS评分和面部表情评分均低于对照组。观察组的心率较低,舒张压高于对照组。观察组不良反应总发生率低于对照组。
    结论:在儿童牙髓疾病的治疗中,使用阿替卡因麻醉效果较好,麻醉起效快,对患者的血压和心率影响较小,但使用药物后也能缓解疼痛,安全性好。值得临床推广应用。
    OBJECTIVE: This trial aimed to study the efficacy of articaine in pain management during endodontic procedures in pediatric patients.
    METHODS: Ninety-eight children who received endodontic painless treatment were collected and randomly divided into the control group and observation group, with 49 cases in each group. The control group received infiltration anesthesia with lidocaine, and the observation group received infiltration anesthesia with articaine. Anesthesia effect, anesthesia onset time, sensory recovery time, duration of anesthesia, pain intensity, blood pressure, heart rate, and adverse reactions were compared.
    RESULTS: The effective rate of anesthesia in the observation group was higher than that in the control group. The anesthesia onset time and sensory recovery time were shorter, the duration of anesthesia was longer, and the VAS score and facial expression score were lower in the observation group than in the control group. The heart rate of the observation group was lower, and diastolic blood pressure was higher than those of the control group. The total incidence of adverse reactions in the observation group was lower than that in the control group.
    CONCLUSIONS: In the treatment of dental pulp diseases in children, the use of articaine can achieve better anesthesia effect and rapid onset of anesthesia and has less impact on the patient\'s blood pressure and heart rate, but it also can relieve pain and has good safety after the use of medication. It is worthy of clinical application.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:新型局部眼部麻醉剂(AG-920无菌眼用溶液,8%)先前在成人中进行了评估。出于临床和监管目的,这种新的药物在儿童中进行了评估。方法:这是一个阶段3,随机,主动控制,单面具,在美国一家私人视网膜诊所进行的健康儿科受试者的平行组设计研究。在60例接受眼科检查的儿童中,比较了AG-920与0.5%盐酸丙对卡因眼用溶液的安全性和麻醉效果。主要疗效终点是研究者是否能够进行眼部检查。结果:在每个治疗组的所有受试者中,研究者无需额外的局部麻醉即可进行眼部检查.在这项研究中没有报告不良事件。在研究之眼和同伴之眼中,给药后没有明显变化,两个治疗组相似。两个治疗组的所有受试者的所有外眼检查均正常。结论:在7个月至>11岁的儿科人群中,AG-920在不需要额外局部麻醉剂的情况下进行眼科检查,与市售的丙对卡因在治疗上等效。Further,AG-920耐受性良好,并且没有临床上显著的安全性发现.
    Purpose: The safety and efficacy of a novel topical ocular anesthetic (AG-920 sterile ophthalmic solution, 8%) was previously evaluated in adults. For both clinical and regulatory purposes, this new agent was evaluated in children. Methods: This was a Phase 3, randomized, active-controlled, single-masked, parallel-group design study in healthy pediatric subjects performed at a private practice retina clinic in the United States. The safety and anesthetic efficacy of AG-920 was compared with proparacaine hydrochloride ophthalmic solution 0.5% in 60 children undergoing ophthalmic examinations. The primary efficacy endpoint was whether the investigator was able to perform the eye examination. Results: In all subjects in each treatment group, the investigator was able to perform the eye examination without additional local anesthetic. There were no adverse events reported in this study. In both the study eye and fellow eye, there were no notable changes after dosing, and both treatment groups were similar. All external eye exams in all subjects in both treatment groups were normal. Conclusions: In this pediatric population aged 7 months to >11 years, AG-920 was therapeutically equivalent to marketed proparacaine with respect to having an ophthalmic examination performed without needing additional local anesthetic. Further, AG-920 was well tolerated, and there were no clinically significant safety findings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:比较中度牙周炎患者接受局部利多卡因凝胶麻醉和阿替卡因注射麻醉的接受度和偏好性。
    方法:91名患者完成了这项随机多中心裂口对照研究,并在不同的日子接受了两次单独的牙周治疗,一种使用局部袋内利多卡因凝胶,另一种使用阿替卡因注射麻醉,顺序不同,具体取决于随机化。测量的参数是患者对局部利多卡因凝胶麻醉或阿替卡因注射麻醉的偏好(主要疗效标准),他们的最大和平均疼痛,和他们的麻木强度以及副作用的经验;探测深度;和牙医的偏好和他们的评估处理/应用,麻醉效果的起效和持续时间,和患者的依从性。
    结果:在经历了两种选择之后,58.3%的患者更喜欢将局部利多卡因凝胶滴入牙周袋。利多卡因凝胶的安全性与阿替卡因注射液的安全性在药物不良反应的类型和频率上存在显著差异。牙医对所研究的两种麻醉方法的接受度和偏好是平衡的。
    结论:将利多卡因凝胶滴入牙周袋是大多数患者注射麻醉的首选方法,也是牙周非手术治疗中牙医的等效方法。
    BACKGROUND: To compare acceptance and preference of topical lidocaine gel anesthesia with articaine injection anesthesia in patients with moderate periodontitis undergoing scaling and root debridement.
    METHODS: Ninety-one patients completed this randomized multicenter split-mouth controlled study and underwent two separate periodontal treatment sessions on different days, one with a topical intrapocket lidocaine gel application and the other with an articaine injection anesthesia in a different order depending on randomization. Parameters measured were the patients\' preference for topical lidocaine gel anesthesia or injection anesthesia with articaine (primary efficacy criterion), their maximum and average pain, and their intensity of numbness as well as experience of side effects; the probing depth; and the dentists\' preference and their evaluations of handling/application, onset and duration of anesthetic effect, and patient compliance.
    RESULTS: After having experienced both alternatives, 58.3% of the patients preferred the topical lidocaine gel instillation into the periodontal pockets. The safety profile of the lidocaine gel differed positively from the safety profile of articaine injection in type and frequency of adverse drug reactions. The dentists\' acceptance and preference regarding either anesthetic method studied were balanced.
    CONCLUSIONS: Instillation of lidocaine gel into the periodontal pocket is a preferred alternative to injection anesthesia for most of the patients and an equivalent alternative for dentists in nonsurgical periodontal therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这项研究的目的是比较和评估小儿人群中2%利多卡因1:80,000肾上腺素和4%阿替卡因1:100,000肾上腺素的疼痛感觉和发作时间。
    对50名9-14岁需要下牙槽神经阻滞(IANB)麻醉的下颌弓双侧牙科治疗的儿童进行了一项裂口随机对照试验。即使在电浆测试(EPT)中施加了最大的电刺激,也没有报告感觉,记录发作时间。使用患者主观症状和面部评分的视觉模拟量表(VAS)评估疼痛感知,腿,活动,哭泣,和由操作者评定的客观疼痛的舒适性(FLACC)量表。
    平均发作时间,疼痛-VAS,FLACC得分分别下降1.31、12.07和18.39%,分别在4%阿替卡因中与2%利多卡因相比,但差异没有达到统计学意义(p>0.05),也就是说,发现统计上是相同的。总之,可以推断,4%阿替卡因的使用与2%利多卡因溶液一样有效,但在儿童中显示麻醉起效和疼痛体验稍好,尽管结果无统计学意义.
    局部麻醉(LA)是儿科实践中疼痛管理的主要方法之一,因此必须选择起效时间较短且给药疼痛较少的LA药物。
    SinghSS,2%利多卡因和4%阿替卡因在小儿下牙槽神经阻滞中的疼痛经历和发作时间的比较评估:一项临床研究。IntJClinPediatrDent2024;17(1):67-71。
    UNASSIGNED: The objective of this research was to conduct a comparison and evaluate the pain perception and time of onset of 2% lignocaine 1:80,000 epinephrine with 4% articaine 1:100,000 epinephrine in the pediatric population.
    UNASSIGNED: A split-mouth randomized control trial was conducted on 50 children aged 9-14 years who required inferior alveolar nerve block (IANB) anesthesia for bilateral dental treatment in the mandibular arch. The time of onset was recorded when no sensation was reported even when maximum electrical stimulus was applied in an electric pulp testing (EPT). The pain perception was assessed using a visual analog scale (VAS) rated by the patient for subjective symptoms and face, legs, activity, cry, and consolability (FLACC) scale for objective pain rated by the operator.
    UNASSIGNED: The mean onset of time, pain-VAS, and FLACC score decreased by 1.31, 12.07, and 18.39%, respectively in 4% articaine as compared to 2% lignocaine but the difference did not reach statistical significance (p > 0.05), that is, found to be statistically the same.In conclusion, it can be inferred that the utilization of 4% articaine is as potent as 2% lignocaine solution but showed slightly better onset of anesthesia and pain experience among the children although the findings were not statistically significant.
    UNASSIGNED: Local anesthesia (LA) is one of the main methods of pain management in pediatric practice which makes it essential to choose an LA agent with a shorter time of onset and less pain on administration.
    UNASSIGNED: Singh SS, Koul M. A Comparative Evaluation of Pain Experience and Time of Onset of 2% Lignocaine and 4% Articaine in Inferior Alveolar Nerve Block among Pediatric Population: A Clinical Study. Int J Clin Pediatr Dent 2024;17(1):67-71.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Randomized Controlled Trial
    目的:评估无针/Comfort-in™方法与常规针法相比阿替卡因的麻醉效果。为了评估麻醉应用期间的疼痛,在牙科急诊预约后,麻醉开始和患者自我报告的与口腔健康相关的生活质量。
    方法:这种并行,随机临床试验由Maranhao州的一名操作人员/牙医进行,巴西东北部。包括的参与者是成年牙科患者,其中一颗磨牙(上颌)或前磨牙(上颌或下颌)牙齿被诊断为有症状的不可逆性牙髓炎。主要结果是麻醉效果,使用电和冷纸浆测试(冷+EPT)和数值评级量表(NRS)的组合进行测量。次要结果是麻醉应用期间的疼痛,麻醉开始,和患者的生活质量(用OHIP-14测量)。
    结果:62例患者随机分为无针麻醉组和舒适组(34.26±10.786×33.29±8.399岁,分别)。Comfort-in组的患者组成功率为71.0%。Comfort-in组患者在麻醉应用期间的疼痛在统计学上低于常规组患者(2.13±2.172×6.03±3.146NRS评分,分别)以及麻醉程序后立即进行。患者自我报告对生活质量的负面影响在牙科急诊之前(p>0.05)和之后(p>0.05)组间相似。
    结论:Comfort-in™具有与常规针法相似的疗效。
    结论:该试验表明,可以在不使用针头的情况下对牙髓坑患者进行麻醉,以主要为焦虑患者提供舒适感。
    OBJECTIVE: To assess the anesthetic efficacy of articaine with the needle-free/Comfort-in™ method compared to the conventional needle method. To assess pain during anesthesia application, onset of anesthesia and patient`s self-reported quality of life-related to oral health after the dental emergency appointment.
    METHODS: This parallel, randomized clinical trial was conducted by a single operator/dentist in the state of Maranhao, northeast of Brazil. Included participants were adult dental patients with one molar (maxillary) or premolar (maxillary or mandibular) tooth diagnosed with symptomatic irreversible pulpitis. The primary outcome was the anesthetic efficacy, measured using a combination of electrical and cold pulp tests (cold + EPT) and the Numerical Rating Scale (NRS). Secondary outcomes were pain during anesthesia application, onset of anesthesia, and patient`s quality-of-life (measured with the OHIP-14).
    RESULTS: 62 patients were randomized in the anesthesia needle-free group and Comfort-in group (34.26 ± 10.786 × 33.29 ± 8.399 years old, respectively). The group of patients in the Comfort-in group had 71.0% success. Patients from the Comfort-in group reported statistically lower pain during the anesthesia application than patients from the conventional group (2.13 ± 2.172 × 6.03 ± 3.146 NRS scores, respectively) as well as immediately after the anesthetic procedure. Patients self-reported negative impact in quality of life was similar between groups before (p > 0.05) and after (p > 0.05) the dental emergency.
    CONCLUSIONS: Comfort-in™ had similar efficacy to the conventional needle method.
    CONCLUSIONS: This trial showed that it is possible to anesthetize patients with tooth pulpits without using needles to provide comfort mainly to anxious patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    无法通过标准口腔浸润实现完全牙髓麻醉,尤其是在SIP用于上颌牙的情况下。该研究旨在比较使用2%利多卡因和4%阿替卡因在永久性上颌第一磨牙中的颊和颊加pal浸润技术的麻醉效果,并诊断为有症状的不可逆性牙髓炎(SIP)。
    临床诊断为SIP的123例患者,18~50岁的患者被随机分配到3个治疗组(N=41).第1组(BIL):使用2%利多卡因和1:80,000肾上腺素的口腔浸润技术。第2组(BPIL):使用2%利多卡因和1:80,000肾上腺素的颊部+腭部浸润的组合。第3组(BIA):使用4%阿替卡因和1:100,000肾上腺素的口腔浸润。在龋齿去除期间的牙髓手术期间,在局部麻醉给药之前和之后记录患者的疼痛强度。使用Heft-Parker视觉模拟量表(HP-VAS)进行访问准备和纸浆去除。成功定义为牙髓手术期间的“无痛(0mm)”或“轻度疼痛(0-54mm)”。使用卡方检验分析麻醉有效率,使用单向方差分析的年龄差异。
    最终分析共包括117名患者。与I组(69%)和III组(74%)相比,II组(85%)的成功率更高,但差异无统计学意义(p>0.05)。我们的结果表明,所有三组的性别之间没有显着差异(p>0.05)。
    使用颊加腭浸润和4%阿替卡因可以为上颌第一磨牙SIP患者提供有效的麻醉作为标准颊浸润和2%利多卡因。
    UNASSIGNED: The inability in achieving complete pulpal anesthesia with standard buccal infiltration especially in cases with SIP used for maxillary teeth. The study aimed to compare the anesthetic efficacy of buccal and buccal plus palatal infiltration technique using 2% lidocaine and 4% articaine in permanent maxillary first molars with the diagnosis of symptomatic irreversible pulpitis (SIP).
    UNASSIGNED: One hundred and twenty-three patients with clinical diagnosis of SIP, aged 18-50 years were randomly allocated to three treatment groups (N = 41). Group 1(BIL): Buccal infiltration technique using 2% lidocaine with 1:80,000 adrenaline. Group 2(BPIL): combination of buccal plus palatal infiltration using 2% Lidocaine with 1:80,000 adrenaline. Group 3(BIA): Buccal infiltration using 4% articaine with 1:100,000 adrenaline. Pain intensity of patients were recorded before and after the administration of local anesthesia during endodontic procedure that is during caries removal, access preparation and pulp removal using Heft-Parker Visual Analog Scale (HP-VAS). Success was defined by \"no pain (0 mm)\" or \"mild pain (0-54 mm)\" during endodontic procedure. The anesthetic efficacy rates were analyzed using chi-square tests, age differences using one-way ANOVA.
    UNASSIGNED: The final analysis included total of 117 patients. Higher success was observed in group II (85%) in comparison to group I (69%) and group III (74%), but the difference was statistically nonsignificant (p > 0.05). Our results demonstrated a nonsignificant difference between genders in all three groups (p > 0.05).
    UNASSIGNED: The use of buccal plus palatal infiltration and 4% articaine can provide effective anesthesia as standard buccal infiltration and 2% lidocaine for patients with SIP in maxillary first molars.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号